The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A randomized phase II trial of intensive induction chemotherapy (CBOP/BEP) and standard BEP in poor prognosis germ cell tumors (MRC TE23, CRUK 05/014, ISRCTN53643604).
R. A. Huddart
No relevant relationships to disclose
R. Gabe
No relevant relationships to disclose
F. Cafferty
No relevant relationships to disclose
P. Pollock
No relevant relationships to disclose
J. D. White
No relevant relationships to disclose
J. Shamash
No relevant relationships to disclose
S. P. Stenning
No relevant relationships to disclose